(Q48701739)

English

Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis.

scientific article published on 10 April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/22488258

0 references

Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis. (English)

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/22488258

0 references

0 references

major depressive disorder

1 reference

based on heuristic

inferred from title

author name string

J G Martins

1

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/22488258

H Bentsen

2

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/22488258

B K Puri

3

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/22488258

language of work or name

0 references

publication date

10 April 2012

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/22488258

Molecular Psychiatry

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/22488258

17

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/22488258

12

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/22488258

1144-9; discussion 1163-7

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/22488258

https://scigraph.springernature.com/pub.10.1038/mp.2012.25

0 references

Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: a randomized, double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

A systematic comparison of software dedicated to meta-analysis of causal studies

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

The efficacy of omega-3 supplementation for major depression: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

21 January 2018

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

7 January 2021

based on heuristic

inferred from DOI database lookup

Omega-3 Fatty Acids as a Treatment for Perinatal Depression: Randomized Double-Blind Placebo-Controlled Trial

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

7 January 2021

based on heuristic

inferred from DOI database lookup

A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty Acids

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

7 January 2021

based on heuristic

inferred from DOI database lookup

A Double-Blind, Placebo-Controlled Study of the Omega-3 Fatty Acid Docosahexaenoic Acid in the Treatment of Major Depression

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.25

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MP.2012.25

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/22488258

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/22488258

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48701739&oldid=1510015865"